Genetec Technology Bhd.

Genetec Technology Bhd.

MMYX:GENETEC
0.27
MYR
-0.01
(-5.36%)
Dec 02Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.27
0.25
31.9
0.28
0.15
0.22
0.18
0.15
0.14
0.33
0.35
0.28
- -
0.13
Basic EPS, GAAP
-0.06
0.02
0.97
0.01
-0.01
0.01
0.01
- -
-0.01
0.08
0.07
-0.04
- -
-0.19
Free Cash Flow per Basic Share
0.04
0.03
-1.33
0.05
0.01
- -
- -
0.02
0.02
-0.15
0.03
-0.15
- -
-0.08
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.02
- -
- -
Book Value per Share
0.1
0.12
0.13
0.14
0.13
0.14
0.14
0.14
0.13
0.25
0.53
0.56
0.37
0.37
Tangible Book Value per Share
0.06
0.07
0.08
0.09
0.09
0.1
0.12
0.13
0.12
0.24
0.52
0.56
0.37
0.37
Basic Weighted Avg Shares
457
457
5
457
457
468
528
550
673
681
690
783
- -
776
Sales/Revenue/Turnover
123
116
146
129
70
101
97
80
97
224
241
223
103
103
Operating Margin (%)
-4.51
1.15
4.09
7.71
-3.14
6.93
14.44
13.09
2.85
28.72
25.26
-11.1
-136.78
-136.78
Depreciation Expense
3
3
3
3
2
2
2
2
3
3
4
7
6
6
Net Income, GAAP
-26
7
4
4
-4
4
6
- -
-4
56
50
-31
-145
-145
Effective Tax Rate (%)
- -
- -
- -
17.81
- -
1.93
- -
- -
- -
6.68
10.54
- -
- -
- -
Profit Margin (%)
-21.05
6.03
3.06
3.42
-5.73
3.62
5.78
-0.21
-4.37
25.23
20.66
-14.08
-140.94
-140.94
Working Capital
- -
-6
12
21
24
38
46
50
49
141
297
302
134
134
LT Debt
21
7
14
13
11
11
10
9
8
9
8
1
1
1
Total Equity
48
53
61
68
63
77
83
82
84
180
410
436
287
287
Return on Invested Capital (%)
- -
- -
- -
8.42
- -
7.74
- -
- -
- -
31.19
14.57
- -
- -
- -
Return on Capital (%)
- -
- -
- -
3.62
- -
3.84
- -
- -
- -
29.59
13.67
- -
- -
- -
Return on Common Equity (%)
-43.25
13.93
8.01
7.36
-6.73
5.77
7.76
-0.22
-5.55
45.31
17.47
-7.52
-40.1
-40.1

Capital Structure

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
ST Debt
100
105
100
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
773
773
773
Market Capitalization
209
131
240

Working Capital

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
Total Current Assets
332
292
257
Cash, Cash Equivalents & STI
56
54
39
Accounts Receivable, Net
143
127
169
Inventories
15
15
12
Total Current Liabilities
155
137
122
Payables & Accruals
- -
- -
- -
ST Debt
100
105
100
Deferred Revenue
- -
- -
- -

Growth Rates

MYR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.87%
43.33%
-34.13%
Free Cash Flow
-290.51%
-320.46%
-43.65%
Net Income, GAAP
78.29%
243.21%
362.18%
Sales/Revenue/Turnover
6.3%
19.5%
-53.82%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
40
63
75
45
223
2026
34
26
20
22
103

Quarterly Earnings Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.01
0.01
- -
-0.06
-0.04
2026
-0.05
-0.09
-0.02
-0.02
- -

Quarterly Dividends Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.02
- -
- -
- -
0.02
2026
- -
- -
- -
- -
- -

Company Description

CEO
Kem Weng Chin
Full Time Employees
345
Sector
Producer manufacturing
Industry
Industrial machinery
Address
Lot 7, Jalan P10/11, Seksyen 10 Bandar Baru Bangi SE Malaysia 43650
IPO Date
Sep 29, 2005
Business
Genetec Technology Berhad designs, manufactures, and sells smart automation systems and customized factory automation equipment, offering a comprehensive range of products including automated assembly lines, robotic pick and place systems, auto fastening, screw driving, dosing systems, plasma treatment, plastic and metal laser welding, material handling solutions, testing and inspection systems, precision tooling jigs and fixtures, and aluminum profile related services. The company's solutions serve multiple industries such as electric vehicle and battery manufacturing, automotive, computer peripherals, healthcare, and consumer goods. Genetec operates globally with a presence in Malaysia, Asia, South America, Europe, and North America, and is headquartered in Bandar Baru Bangi, Malaysia, having been incorporated in 1997. Recent major developments include Genetec's expansion into new product lines and markets, notably securing over RM100 million in new orders for body panel assembly for a North American electric vehicle client, marking its first venture beyond battery cells and pack assembly. The company is also diversifying into the semiconductor industry with a proof-of-concept automation line for wafer deposition equipment for a U.S.-based semiconductor manufacturer, indicating a strategic shift into front-end semiconductor automation. Additionally, the company changed its financial year-end from March 31 to June 30, extending the current financial year to a 15-month period ending June 30, 2024. There is also a plan for the disposal of a 51% stake in CLT Engineering to improve operational focus. Genetec continues to expand its client base and business scope globally while enhancing its technological capabilities in electric vehicle assembly, semiconductor automation, and other advanced manufacturing services.